WO2003087300A3 - Secreted proteins - Google Patents

Secreted proteins Download PDF

Info

Publication number
WO2003087300A3
WO2003087300A3 PCT/US2003/010249 US0310249W WO03087300A3 WO 2003087300 A3 WO2003087300 A3 WO 2003087300A3 US 0310249 W US0310249 W US 0310249W WO 03087300 A3 WO03087300 A3 WO 03087300A3
Authority
WO
WIPO (PCT)
Prior art keywords
secp
secreted proteins
polynucleotides
agonists
diagnosing
Prior art date
Application number
PCT/US2003/010249
Other languages
French (fr)
Other versions
WO2003087300A2 (en
Inventor
Joseph P Marquis
Soo Y Lee
Vicki S Elliott
Jayalaxmi Ramkumar
April J A Hafalia
Amy E Kable
Narinder K Chawla
Brooke M Emerling
Reena Khare
Xin Jiang
Alan A Jackson
Phillip R Hawkins
Pei Jin
Patricia M Mason
Thomas W Richardson
Anita Swarnakar
Preeti G Lal
Bridget A Warren
Sally Lee
Jennifer A Griffin
Glenn K Fu
Amy D Wilson
Yuming Xu
Sean A Bulloch
Shanya D Becha
Umesh G Bhatia
John D Burrill
Julie J Blake
Anne Ho
Wenjin Zheng
Original Assignee
Incyte Corp
Joseph P Marquis
Soo Y Lee
Vicki S Elliott
Jayalaxmi Ramkumar
April J A Hafalia
Amy E Kable
Narinder K Chawla
Brooke M Emerling
Reena Khare
Xin Jiang
Alan A Jackson
Phillip R Hawkins
Pei Jin
Patricia M Mason
Thomas W Richardson
Anita Swarnakar
Preeti G Lal
Bridget A Warren
Sally Lee
Jennifer A Griffin
Glenn K Fu
Amy D Wilson
Yuming Xu
Sean A Bulloch
Shanya D Becha
Umesh G Bhatia
John D Burrill
Julie J Blake
Anne Ho
Wenjin Zheng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Joseph P Marquis, Soo Y Lee, Vicki S Elliott, Jayalaxmi Ramkumar, April J A Hafalia, Amy E Kable, Narinder K Chawla, Brooke M Emerling, Reena Khare, Xin Jiang, Alan A Jackson, Phillip R Hawkins, Pei Jin, Patricia M Mason, Thomas W Richardson, Anita Swarnakar, Preeti G Lal, Bridget A Warren, Sally Lee, Jennifer A Griffin, Glenn K Fu, Amy D Wilson, Yuming Xu, Sean A Bulloch, Shanya D Becha, Umesh G Bhatia, John D Burrill, Julie J Blake, Anne Ho, Wenjin Zheng filed Critical Incyte Corp
Priority to AU2003222189A priority Critical patent/AU2003222189A1/en
Publication of WO2003087300A2 publication Critical patent/WO2003087300A2/en
Publication of WO2003087300A3 publication Critical patent/WO2003087300A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Various embodiments of the invention provide human secreted proteins (SECP)and polynucleotides which identify and encode SECP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
PCT/US2003/010249 2002-04-05 2003-04-01 Secreted proteins WO2003087300A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003222189A AU2003222189A1 (en) 2002-04-05 2003-04-01 Secreted proteins

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US37070702P 2002-04-05 2002-04-05
US60/370,707 2002-04-05
US37382402P 2002-04-19 2002-04-19
US60/373,824 2002-04-19
US37788302P 2002-05-03 2002-05-03
US60/377,883 2002-05-03
US38321802P 2002-05-24 2002-05-24
US60/383,218 2002-05-24

Publications (2)

Publication Number Publication Date
WO2003087300A2 WO2003087300A2 (en) 2003-10-23
WO2003087300A3 true WO2003087300A3 (en) 2006-08-24

Family

ID=29255575

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/010249 WO2003087300A2 (en) 2002-04-05 2003-04-01 Secreted proteins

Country Status (2)

Country Link
AU (1) AU2003222189A1 (en)
WO (1) WO2003087300A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394330B2 (en) 2012-03-21 2016-07-19 Alios Biopharma, Inc. Solid forms of a thiophosphoramidate nucleotide prodrug

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638270B2 (en) 2003-01-24 2009-12-29 Agensys, Inc. Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
CN103209987B (en) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 Substituted nucleotide analog
SG194099A1 (en) 2011-04-15 2013-11-29 Compugen Ltd Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer
AU2012358804B2 (en) 2011-12-22 2018-04-19 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001075067A2 (en) * 2000-03-31 2001-10-11 Hyseq, Inc. Novel nucleic acids and polypeptides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
COLLINS F.S.: "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.", PNAS, vol. 99, no. 26, 24 December 2002 (2002-12-24), WASHINGTON, DC, US, pages 16899 - 16903, XP002309773 *
SALBAUM J.M.: "GENOMIC STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE MOUSE GENE PUNC.", MAMMALIAN GENOME, vol. 10, no. 2, February 1999 (1999-02-01), NEW YORK, NY, US, pages 107 - 111, XP000992754 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9394330B2 (en) 2012-03-21 2016-07-19 Alios Biopharma, Inc. Solid forms of a thiophosphoramidate nucleotide prodrug

Also Published As

Publication number Publication date
WO2003087300A2 (en) 2003-10-23
AU2003222189A1 (en) 2003-10-27
AU2003222189A8 (en) 2003-10-27

Similar Documents

Publication Publication Date Title
WO2003027228A3 (en) Receptors and membrane-associated proteins
WO2002038602A3 (en) Secreted proteins
WO2003048305A3 (en) Receptors and membrane-associated proteins
WO2001098353A3 (en) Secreted proteins
WO2002048337A3 (en) Secreted human proteins
WO2003029437A3 (en) Secreted proteins
WO2002072794A3 (en) Immunoglobulin superfamily proteins
WO2001079291A3 (en) Secreted proteins
WO2003004615A3 (en) Secreted proteins
WO2003070902A3 (en) Receptors and membrane-associated proteins
WO2003068943A3 (en) Secreted proteins
WO2002070669A3 (en) Secreted proteins
WO2002086069A3 (en) Secreted proteins
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2004044165A3 (en) Lipid-associated proteins
WO2004048550A3 (en) Immune response associated proteins
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2002026982A3 (en) Secreted human proteins
WO2003087300A3 (en) Secreted proteins
WO2003025130A3 (en) Receptors and membrane-associated proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2003016506A3 (en) Secreted proteins
WO2002079441A3 (en) Secreted proteins
WO2003063769A3 (en) Vesicle-associated proteins
WO2001051636A3 (en) Secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP